Drugmakers, retailers must face ‘maximum strength’ claim in decongestant false ad litigation in US
The 2nd U.S. Circuit Court of Appeals revived claims against drugmakers and retailers over false 'maximum strength' decongestant labeling despite FDA preemption.
J&J reaches sweeping talc deal that could end decade of litigation
Johnson & Johnson said it would pay an estimated $5.5 billion to resolve tens of thousands of lawsuits alleging its baby powder and other talc products cause ovarian cancer.
J&J enters US robotic surgery market after device gets marketing authorization
Johnson & Johnson's robotic surgery system gains FDA marketing authorization for multiple upper abdomen procedures, entering the US market.
Fines for slow pretrial mental healthcare upheld against MD Health Department
The Maryland Supreme Court upheld fines against the state health department for failing to provide prompt psychiatric care to criminal defendants deemed incompetent to stand trial.
Novo sues Lilly, claiming misleading ads in weight-loss drug battle
Novo Nordisk sued Eli Lilly in U.S. court, alleging false advertising claims about weight-loss drugs Zepbound and Wegovy, seeking corrective ads and damages.
FDA says data continues to support Taylor Farms’ lettuce as cyclospora source
The FDA confirmed the cyclospora finding in Taylor Farms lettuce was a false positive and no positive samples have been identified amid outbreak concerns.
What to know about cyclosporiasis cases in MD, DC, VA
As reports of cyclosporiasis grow across the country, there’s also been a slight uptick in cases of the gastrointestinal illness in Maryland.
Three companies to join Howard County business community
Through a joint venture between Greenebaum Enterprises Inc. and St. John Properties Inc., three tenants will be joining Montpelier Research Park in Laurel.
Stephen Snyder case: Conviction of med-mal attorney upheld
The conviction for attempted extortion by Maryland medical malpractice attorney Stephen Snyder has been upheld.
CVS settles with FTC, agrees to count TrumpRx drug purchases toward insurance
CVS finalized a settlement with the FTC in which it agreed to curb use of rebates and count consumers' TrumpRx purchases toward their deductibles.
Appeals court revives hundreds of private lawsuits linking Tylenol to autism
The 2nd U.S. Circuit Court of Appeals revived more than 500 lawsuits linking Tylenol to autism and ADHD, allowing excluded testimony.
AstraZeneca employee in MD accused of insider trading
An employee of the pharmaceutical giant AstraZeneca is accused of insider trading after allegedly buying stock in a company shortly before it was acquired by his employer.


















